Dr. Hadassah Sade: Transforming Diagnostics and Treatment Through Computational Pathology April 09-11, 2026 | Dubai , UAE
Introduction The future of precision medicine is being reshaped by artificial intelligence and computational pathology—and at the forefront of this transformation stands Dr. Hadassah Sade, Managing Director of Computational Pathology at AstraZeneca, Germany. With a strong vision for integrating deep learning, digital pathology, and translational data science, Dr. Sade is redefining how diagnostics and therapeutic decisions are made in modern healthcare. Dr. Sade will be delivering an impactful talk titled: “Transforming Diagnostics and Treatment Through Computational Pathology: A Deep Learning Approach for Precise Biomarker Quantification and Patient Selection.” Her session promises cutting-edge insights into how AI-driven pathology is revolutionizing drug development and patient care. Conference Details Conference: World Digital Pathology & AI UCG Congress Format: In-Person & Virtual Participation Available Location: Dubai, UAE Theme: Advancing Digital Pathology, Artificial In...